Atlas Trials

Lisdexamfetamine in Binge Eating Disorder (BED): fMRI Effects

Clinical trial NCT02659488 · UNKNOWN

Trial details

NCT number
NCT02659488
Sponsor
Lindner Center of HOPE
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Binge Eating Disorder
Start date
2015-09-01
Primary completion
2017-09-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.